Shamburg News · 8-K filed Oct 13, 2026, 4:06 PM EDT
Retension Pharmaceuticals Adopts Amended Charter and Bylaws Ahead of IPO Closing
RTSN · Retension Pharmaceuticals, Inc.
- Other event
- Materiality: low
Retension Pharmaceuticals, Inc. filed its Third Amended and Restated Certificate of Incorporation with the Delaware Secretary of State on October 9, 2026, in connection with the closing of its initial public offering on October 13, 2026. Its Amended and Restated Bylaws, previously approved by the board and stockholders, also became effective immediately prior to the IPO closing. The amended charter and bylaws are filed as Exhibits 3.1 and 3.2.
Source: SEC EDGAR, Form 8-K, Items 5.03, 9.01, accession 0001213900-26-109024.
Written from the filing by Shamburg Markets. Figures are as reported by the company.